Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Trichilemmoma, BCC, and SCC tumors have different stem cell marker expressions.

Clouston Syndrome can be linked to rare sweat gland tumors.

Cats with adrenal tumors may have both hyperaldosteronism and hyperprogesteronism.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

ABCG2 protein marks stem-like skin cells in human epidermis.

Pigmented papules on the ear can be a rare skin condition called cutaneous amyloidosis, treatable with topical tretinoin.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Hair follicles and sweat glands show different keratin staining patterns.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

The cat's skin condition was linked to cancer and did not improve with treatment, leading to a poor outcome.

Surgery successfully treated the ferret's adrenal issue, leading to hair regrowth and improved health.

Neoplasms hide in hair follicles to avoid the immune system.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Steroid cell tumors in the ovary are rare, can cause hormone-related symptoms, and require surgery.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

PRP can improve hair growth in people with hair loss, but more research is needed.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.